Market Overview

Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Highest ROA

Share:
Related LH
UPDATE: Credit Suisse Upgrades Laboratory Corporation Of America As Guidance Remains Interesting
Benzinga's Top Upgrades
Related DGX
Bank of America Downgrades Quest Diagnostics To Underperform
Benzinga's Top Downgrades

Below are the top mid-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of return on assets.

The trailing-twelve-month return on assets at Laboratory Corp. of America Holdings (NYSE: LH) is 10.96%. Laboratory Corp. of America's operating margin for the same period is 19.31%.

The trailing-twelve-month return on assets at Quest Diagnostics (NYSE: DGX) is 9.00%. Quest Diagnostics's PEG ratio is 1.03.

The trailing-twelve-month return on assets at Covance (NYSE: CVD) is 6.03%. Covance's revenue for the same period is $2.12 billion.

The trailing-twelve-month return on assets at Life Technologies (NASDAQ: LIFE) is 5.79%. Life Technologies had $247.43 million in total cash for the recent quarter.

Posted-In: Highest ROA Medical Laboratories & Research Industry Mid-CapTrading Ideas

 

Related Articles (CVD + DGX)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→